Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting.
作者信息
Fleseriu Maria
机构信息
Pituitary Center, and Departments of Medicine (Endocrinology, Diabetes and Clinical Nutrition), and Neurological Surgery, Oregon Health & Science University, Portland, OR, United States.
出版信息
Front Endocrinol (Lausanne). 2021 Mar 12;12:656025. doi: 10.3389/fendo.2021.656025. eCollection 2021.
Abstract
摘要
相似文献
1
Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting.垂体疾病与新冠疫情：重塑医疗护理，大流行已过去一年且仍在持续
Front Endocrinol (Lausanne). 2021 Mar 12;12:656025. doi: 10.3389/fendo.2021.656025. eCollection 2021.
2
One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology.疫情一年之际——欧洲内分泌学家如何应对危机：欧洲内分泌学会的声明。
Eur J Endocrinol. 2021 Jul 5;185(2):C1-C7. doi: 10.1530/EJE-21-0397.
3
(Our response to) COVID-19: In science we trust.我们对新冠疫情的应对：我们信赖科学。
Endocrine. 2021 Jan;71(1):1-2. doi: 10.1007/s12020-021-02608-1.
4
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study.COVID-19 大流行对垂体疾病患者护理的直接和间接影响：一项横断面研究。
Pituitary. 2021 Apr;24(2):262-268. doi: 10.1007/s11102-020-01106-3. Epub 2020 Nov 24.
5
COVID-19 alters thinking and management in metabolic diseases.COVID-19 改变了代谢性疾病的思维和管理方式。
Nat Rev Endocrinol. 2021 Feb;17(2):71-72. doi: 10.1038/s41574-020-00449-y.
6
Pituitary Disorders: Striving for Excellence.垂体疾病：追求卓越。
Endocrinol Metab Clin North Am. 2020 Sep;49(3):xvii-xviii. doi: 10.1016/j.ecl.2020.06.001. Epub 2020 Jul 15.
7
COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them?新型冠状病毒肺炎、酮症酸中毒与新发糖尿病：它们之间是否存在可能的因果关系？
Diabetes Obes Metab. 2020 Dec;22(12):2507-2508. doi: 10.1111/dom.14170. Epub 2020 Aug 27.
8
An invisible hand has guided clinical endocrinology toward an unexpected future.一只无形的手已将临床内分泌学引向意想不到的未来。
J Endocrinol Invest. 2020 Jul;43(7):1037-1038. doi: 10.1007/s40618-020-01256-y. Epub 2020 Apr 20.
9
A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part I.一个百年两疫的故事：1918 年流感大流行和 COVID-19，第一部分。
Am J Public Health. 2021 Jun;111(6):1086-1094. doi: 10.2105/AJPH.2021.306310.
10
Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective.垂体学会指导意见：COVID-19 大流行期间的垂体疾病管理和患者护理建议——国际视角。
Pituitary. 2020 Aug;23(4):327-337. doi: 10.1007/s11102-020-01059-7.
引用本文的文献
1
Endocrine Disorders and COVID-19 Severity in Pediatric Populations: A Systematic Review.儿科人群中的内分泌疾病与新冠病毒疾病严重程度：一项系统综述
Cureus. 2025 Jul 21;17(7):e88458. doi: 10.7759/cureus.88458. eCollection 2025 Jul.
2
Pituitary Apoplexy: Description of Medical and Surgical Treatment and Clinical, Visual, and Endocrinological Outcomes During the SARS-CoV-2 Pandemic and Over Three Years.垂体卒中：SARS-CoV-2大流行期间及三年多来的内科和外科治疗描述以及临床、视觉和内分泌学结果
Cureus. 2024 Jun 25;16(6):e63152. doi: 10.7759/cureus.63152. eCollection 2024 Jun.
3
Pituitary surgery and COVID.垂体手术与新冠病毒
Pituitary. 2024 Dec;27(6):909-915. doi: 10.1007/s11102-024-01423-x. Epub 2024 Jul 5.
4
Acromegaly and COVID-19, lessons, and new opportunities.肢端肥大症与2019冠状病毒病：经验教训与新机遇
Pituitary. 2024 Dec;27(6):935-944. doi: 10.1007/s11102-024-01404-0. Epub 2024 May 31.
5
Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly.COVID-19 大流行对肢端肥大症患者疾病控制状况和生活质量的影响。
Medicina (Kaunas). 2022 Nov 23;58(12):1711. doi: 10.3390/medicina58121711.
6
Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.奥曲肽治疗库欣综合征：病例举例介绍近期研究的实际应用。
Pituitary. 2022 Dec;25(6):795-809. doi: 10.1007/s11102-022-01268-2. Epub 2022 Aug 24.
7
Successful Immunomodulatory Treatment of COVID-19 in a Patient With Severe ACTH-Dependent Cushing's Syndrome: A Case Report and Review of Literature.COVID-19 成功的免疫调节治疗：一例严重 ACTH 依赖性库欣综合征患者的病例报告及文献复习。
Front Endocrinol (Lausanne). 2022 Jun 22;13:889928. doi: 10.3389/fendo.2022.889928. eCollection 2022.
8
Optic neuritis concomitant with pituitary macroadenoma in a patient with active COVID-19 infection: A case report.一名患有活动性新冠病毒感染的患者出现视神经炎合并垂体大腺瘤：病例报告
Int J Surg Open. 2021 Sep;35:100390. doi: 10.1016/j.ijso.2021.100390. Epub 2021 Aug 25.
9
COVID-19 and hypopituitarism.新型冠状病毒肺炎与垂体功能减退症。
Rev Endocr Metab Disord. 2022 Apr;23(2):215-231. doi: 10.1007/s11154-021-09672-y. Epub 2021 Aug 13.
本文引用的文献
1
Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center.COVID-19 时的肾上腺功能不全：三级中心就诊患者的回顾性研究。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1354-e1361. doi: 10.1210/clinem/dgaa793.
2
Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.二甲双胍的使用与 COVID-19 合并糖尿病的多样化患者人群死亡率降低相关。
Front Endocrinol (Lausanne). 2021 Jan 13;11:600439. doi: 10.3389/fendo.2020.600439. eCollection 2020.
3
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era.ACROCOVID 研究结果：COVID-19 时代肢端肥大症治疗的国际调查。
Endocrine. 2021 Feb;71(2):273-280. doi: 10.1007/s12020-020-02565-1. Epub 2021 Jan 7.
4
Hypertension and Electrolyte Disorders in Patients with COVID-19.新型冠状病毒肺炎患者的高血压和电解质紊乱
Electrolyte Blood Press. 2020 Dec;18(2):23-30. doi: 10.5049/EBP.2020.18.2.23. Epub 2020 Dec 28.
5
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.成功治疗一名患有活动性库欣病并合并2019冠状病毒病（COVID-19）肺炎的患者。
Endocr J. 2021 Apr 28;68(4):477-484. doi: 10.1507/endocrj.EJ20-0613. Epub 2020 Dec 24.
6
Early practices in endonasal skull base surgery during the COVID-19 pandemic: a global survey.COVID-19 大流行期间经鼻颅底外科早期实践：全球调查。
Neurosurg Focus. 2020 Dec;49(6):E12. doi: 10.3171/2020.9.FOCUS20569.
7
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study.COVID-19 大流行对垂体疾病患者护理的直接和间接影响：一项横断面研究。
Pituitary. 2021 Apr;24(2):262-268. doi: 10.1007/s11102-020-01106-3. Epub 2020 Nov 24.
8
Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis.生长激素缺乏症、肢端肥大症与2019冠状病毒病：从媒体报道到知识及生长激素假说的转变
Growth Horm IGF Res. 2021 Feb;56:101363. doi: 10.1016/j.ghir.2020.101363. Epub 2020 Nov 13.
9
Rare Case of a Disappearing Pituitary Adenoma During the Coronavirus Disease 2019 (COVID-19) Pandemic.COVID-19 期间垂体腺瘤消失的罕见病例
World Neurosurg. 2021 Feb;146:148-149. doi: 10.1016/j.wneu.2020.11.073. Epub 2020 Nov 18.
10
Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas.抑郁和冲动自我评估工具，以识别垂体腺瘤患者多巴胺激动剂的副作用。
Front Endocrinol (Lausanne). 2020 Oct 27;11:579606. doi: 10.3389/fendo.2020.579606. eCollection 2020.
Zotero 插件